EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

被引:544
作者
Combe, B.
Landewe, R.
Lukas, C.
Bolosiu, H. D.
Breedveld, F.
Dougados, M.
Emery, P.
Ferraccioli, G.
Hazes, J. M. W.
Klareskog, L.
Machold, K.
Martin-Mola, E.
Nielsen, H.
Silman, A.
Smolen, J.
Yazici, H.
机构
[1] Lapeyronie Hosp, Montpellier, France
[2] Univ Hosp Maastricht, Maastricht, Netherlands
[3] Univ Med, Rheumatol & Res Ctr, Cluj Napoca, Romania
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
[5] Cochin Hosp, Paris, France
[6] Acad Unit Musculoskeletal Dis, Leeds, W Yorkshire, England
[7] Univ Cattolica Sacro Cuore, Div Rheumatol, I-00168 Rome, Italy
[8] Erasmus MC, Rotterdam, Netherlands
[9] Karolinska Hosp, S-10401 Stockholm, Sweden
[10] Med Univ Vienna, Vienna, Austria
[11] Hosp La Paz, Madrid, Spain
[12] Herlev Univ Hosp, DK-2730 Herlev, Denmark
[13] Univ Manchester, ARC Unit, Manchester, Lancs, England
[14] Cerrahpasa Med Fac, Istanbul, Turkey
关键词
D O I
10.1136/ard.2005.044354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To formulate EULAR recommendations for the management of early arthritis. Methods: In accordance with EULAR's "standardised operating procedures'', the task force pursued an evidence based approach and an approach based on expert opinion. A steering group comprised of 14 rheumatologists representing 10 European countries. The group defined the focus of the process, the target population, and formulated an operational definition of "management''. Each participant was invited to propose issues of interest regarding the management of early arthritis or early rheumatoid arthritis. Fifteen issues for further research were selected by use of a modified Delphi technique. A systematic literature search was carried out. Evidence was categorised according to usual guidelines. A set of draft recommendations was proposed on the basis of the research questions and the results of the literature search.. The strength of the recommendations was based on the category of evidence and expert opinion. Results: 15 research questions, covering the entire spectrum of "management of early arthritis'', were formulated for further research; and 284 studies were identified and evaluated. Twelve recommendations for the management of early arthritis were selected and presented with short sentences. The selected statements included recognition of arthritis, referral, diagnosis, prognosis, classification, and treatment of early arthritis (information, education, non-pharmacological interventions, pharmacological treatments, and monitoring of the disease process). On the basis of expert opinion, 11 items were identified as being important for future research. Conclusions: 12 key recommendations for the management of early arthritis or early rheumatoid arthritis were developed, based on evidence in the literature and expert consensus.
引用
收藏
页码:34 / 45
页数:12
相关论文
共 158 条
  • [11] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    Breedveld, FC
    Weisman, MH
    Kavanaugh, AF
    Cohen, SB
    Pavelka, K
    van Vollenhoven, R
    Sharp, J
    Perez, JL
    Spencer-Green, GT
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 26 - 37
  • [12] Brennan P, 1996, BRIT MED J, V313, P471
  • [13] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
    Bresalier, RS
    Sandler, RS
    Quan, H
    Bolognese, JA
    Oxenius, B
    Horgan, K
    Lines, C
    Riddell, R
    Morton, D
    Lanas, A
    Konstam, MA
    Baron, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) : 1092 - 1102
  • [14] Brosseau L, 2004, PHYS THER, V84, P934
  • [15] Brosseau L., 2000, COCHRANE DB SYST REV
  • [16] Radiography as primary outcome in rheumatoid arthritis:: acceptable sample sizes for trials with 3 months' follow up
    Bruynesteyn, K
    Landewé, R
    van der Linden, S
    van der Heijde, D
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) : 1413 - 1418
  • [17] BUCKLANDWRIGHT JC, 1993, J RHEUMATOL, V20, P243
  • [18] Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis - Results from the Norfolk Arthritis Register study, a large inception cohort
    Bukhari, M
    Lunt, M
    Harrison, BJ
    Scott, DGI
    Symmons, DPM
    Silman, AJ
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (04): : 906 - 912
  • [19] Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years - Results from a large observational inception study
    Bukhari, MAS
    Wiles, NJ
    Lunt, M
    Harrison, BJ
    Scott, DGI
    Symmons, DPM
    Silman, AJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (01): : 46 - 53
  • [20] Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial
    Capell, HA
    Madhok, R
    Hunter, JA
    Porter, D
    Morrison, E
    Larkin, J
    Thomson, EA
    Hampson, R
    Poon, FW
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (07) : 797 - 803